Aurobindo Pharma snaps 12-day winning streak after USFDA update on subsidiary's API unit

Aurobindo Pharma shares fell nearly 2% after the US FDA issued a Form 483 with a VAI classification for its subsidiary Apitoria Pharma Private Limited's manufacturing facility.